These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33393329)

  • 1. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy.
    Ranzenigo M; Ceccarelli D; Galli L; Bertoni C; Siribelli A; Messina E; Hasson H; Lolatto R; Castagna A; Uberti-Foppa C; Morsica G
    New Microbiol; 2023 Sep; 46(3):296-302. PubMed ID: 37747475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term postoperative outcomes of colorectal cancer among patients with chronic liver disease: a national population-based study.
    Lee KC; Chung KC; Chen HH; Cheng KC; Wu KL; Lu CC
    BMJ Open; 2018 Jul; 8(7):e020511. PubMed ID: 30018094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease.
    Crothers K; Adams SV; Turner AP; Batten L; Nikzad R; Kundzins JR; Fan VS
    Ann Am Thorac Soc; 2024 Jul; 21(7):1034-1043. PubMed ID: 38530061
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
    Riou M; Marcot C; Canuet M; Renaud-Picard B; Chatron E; Porzio M; Dégot T; Hirschi S; Metz-Favre C; Kassegne L; Ederle C; Khayath N; Labani A; Leyendecker P; De Blay F; Kessler R;
    Respir Med Res; 2021 May; 79():100801. PubMed ID: 33259989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19.
    Grgurevic I; Lucijanić M; Pastrovic F; Barisic Jaman M; Tjesic Drinkovic I; Zelenika M; Milosevic M; Medic B; Kardum D; Bokun T; Luksic I; Piskac Zivkovic N; Keres T; Grabovac V; Persec J; Barsic B
    Intern Med J; 2022 Nov; 52(11):1891-1899. PubMed ID: 35555962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.
    Garrido M; Pereira Guedes T; Alves Silva J; Falcão D; Novo I; Archer S; Rocha M; Maia L; Sarmento-Castro R; Pedroto I
    GE Port J Gastroenterol; 2021 Jan; 158(4):1-12. PubMed ID: 34192127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Pletcher MJ; Lai JC;
    Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb-
    Jing J; Wang RL; Zhao XY; Zhu Y; Niu M; Wang LF; Song XA; He TT; Sun YQ; Xu WT; Yu SM; Wang LP; Guo YM; Bai ZF; Xiao XH; Wang JB
    BMJ Open; 2019 Jan; 9(1):e023567. PubMed ID: 30782709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic liver disease not a significant comorbid condition for COVID-19.
    Lin J; Bao B; Khurram NA; Halsey K; Choi JW; Wang L; Tran TML; Liao WH; Feldman MD; Zhang PJ; Wu J; Bai HX
    Sci Rep; 2021 Jun; 11(1):11734. PubMed ID: 34083670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of liver injury in risk-stratification and management of patients with COVID-19.
    Shao J; Liang Y; Li Y; Ding R; Zhu M; You W; Wang Z; Huang B; Wu M; Zhang T; Li K; Wu W; Wu L; Wang Q; Xia X; Wang S; Lu L
    Hepatol Int; 2021 Feb; 15(1):202-212. PubMed ID: 33548030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.
    Wu PJ; Feng IC; Lai CC; Ho CH; Kan WC; Sheu MJ; Kuo HT
    PeerJ; 2023; 11():e16582. PubMed ID: 38077441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
    Kulkarni AV; Kumar P; Tevethia HV; Premkumar M; Arab JP; Candia R; Talukdar R; Sharma M; Qi X; Rao PN; Reddy DN
    Aliment Pharmacol Ther; 2020 Aug; 52(4):584-599. PubMed ID: 32638436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
    Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
    BMC Gastroenterol; 2021 Nov; 21(1):439. PubMed ID: 34814851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.